LIS Technologies develops patented laser isotope separation technology to efficiently enrich uranium for both Low-Enriched Uranium (LEU) used in existing nuclear reactors and High-Assay Low-Enriched Uranium (HALEU) for next-generation Small Modular Reactors (SMRs). This technology offers a scalable and cost-effective alternative to traditional enrichment methods, addressing the need for more efficient uranium processing in the nuclear energy sector.
Funding
$22.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional uranium enrichment methods, such as gas diffusion and centrifuges, are energy-intensive, costly, and often foreign-owned. Existing laser enrichment technologies have struggled to achieve scalable and cost-effective deployment despite their potential for superior efficiency.
Solution
LIS Technologies (LIST) is developing a patented laser isotope separation technology designed to efficiently enrich uranium. This technology uses infrared lasers to selectively excite and separate desired uranium isotopes, offering a potentially more energy-efficient and cost-competitive alternative to conventional enrichment methods. LIST's process is optimized for producing Low-Enriched Uranium (LEU) for existing nuclear reactors and High-Assay Low-Enriched Uranium (HALEU) for next-generation Small Modular Reactors (SMRs) and microreactors. The company's Condensation Repression Isotope Selective Laser Activation (CRISLA) technology aims to provide a scalable and economically viable solution for uranium enrichment.
Target Audience
The primary target audience includes nuclear power plants requiring LEU, developers of Small Modular Reactors (SMRs) and microreactors needing HALEU, and organizations involved in stable isotope production for medical and scientific research.
Features
- Patented laser isotope separation technology utilizing infrared lasers
- Optimized for both Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU) production
- Aims for superior energy efficiency compared to gas diffusion and centrifuge methods
- Scalable design for deployment in various nuclear energy applications
- Condensation Repression Isotope Selective Laser Activation (CRISLA) technology